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Abstract: Individual disclosure refers to the presumptive ethical responsi-
bility of an investigator to communicate to a study participant information
that was collected as a part of a research study protocol and is speciﬁc to
the individual. Currently, there are no federal regulatory guidelines
specifying the conditions and management of disclosure of health-related
individual-speciﬁc information. In this report, the authors discuss the chal-
lenges associated with individual disclosure in the context of a longitudinal
descriptive study. Arguments favoring disclosure and those challenging
disclosure as a general ethical duty are presented. Finally, strategies for
addressing individual disclosure are discussed using a research exemplar
in which risk behaviors related to health outcomes were measured.  2013
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Disclosure of individual ﬁndings is a chal-
lenging ethical issue in the design and imple-
mentation of clinical research. Individual
ﬁndings include information about a research
participant discovered during the course of a re-
search project, which would likely, if disclosed
to the participant, make a difference to that
participant’s ability to plan for his or her well-
being. In contrast to aggregate ﬁndings for
which there are clearer ethical mandates regard-
ing communication both to study participants
and the scientiﬁc community (Fernandez, Kodish,
& Weijer, 2003), obligations regarding the
communication of individual-speciﬁc ﬁndings
to study participants remain controversial and
unclear. Currently few laws or guidelines are
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available to support decisions about individual
disclosure, and across institutional review
boards little consensus exists (Gordon, 2009;
Miller, Christensen, Giacomini, & Robert, 2008;
Stein, 2009). Consequently, investigators are
unlikely to consider this important issue in plan-
ning their studies, and well-thought-out plans
for managing potentially critical clinical infor-
mation within the context of a complex study
protocol may be lacking.
Clinical research studies often include the
collection of data that may reveal an undiag-
nosed health problem or a potentially alterable
proﬁle that confers increased risk for disease
or disability. Creando Posibilidades [Creating
Possibilities] was a study of determinants of
disordered eating (DE) behaviors in a sample
of young adult Mexican-American women, in
which ecological momentary assessment (EMA)
was used to measure eight DE behaviors. A de-
tailed review of the behavioral patterns recorded
during the EMA, when integrated with the atti-
tudinal measures, might have been used to iden-
tify women meeting diagnostic criteria for an
eating disorder. As the investigators proceeded
with design and implementation of Creando
Posibilidades, our research team considered the
obligation to review each participant’s data to
determine if signs and symptoms of an eating
disorder were present, and if so, whether the
participant should be informed, and when and
how. The overall purpose of this paper is to dis-
cuss the issue of individual disclosure and to
describe how these questions were addressed
within the context of this community-based
12-month longitudinal study. Basic issues that
should be considered regarding individual dis-
closure during the planning stages of health-
related risk behavior studies also are discussed.
Disclosure of individual results refers
to the presumptive ethical responsibility of an
investigator to communicate to the study partici-
pant information speciﬁc to the individual that
was collected as part of the research study pro-
tocol (Shalowitz & Miller, 2005). Disclosure
is predicated upon the principles of ethical
research that include respect for persons and
avoidance of harms. Individual disclosure
extends the more broadly accepted ethical duty
of group disclosure (Miller et al., 2008). The
issue of individual disclosure emerged earlier
in this decade as a pressing and contentious
issue in the context of genetic research. Genetic
ﬁndings have the potential to inﬂuence repro-
ductive decisions, lifestyle choices, health
behaviors, family relationships, and employment
opportunities and beneﬁts, as well as attitudes
and behaviors toward speciﬁc groups. Within
this context, ethicists began to examine and
debate study participants’ ‘‘right to know.’’
Although the issue of individual disclosure was
initiated in the area of genetic research, there is
growing consensus that it is relevant across
many domains of biomedical research (Miller
et al., 2008).
The issue of disclosure of ﬁndings to indi-
viduals is compounded by the complexity of
legal and ethical responsibilities that confront
investigators, and it varies within the context of
the study and the nature of study participants.
For example, state laws generally require dis-
closure of conﬁdential information without a
client’s consent when there is reason to believe
that a client poses a serious, imminent, and
foreseeable threat to an identiﬁable third party,
such as when a police ofﬁcer requests conﬁden-
tial information about a client. In this case,
the investigator must consider legal guidelines
pertaining to the disclosure of conﬁdential infor-
mation to a law enforcement ofﬁcial without a
client’s consent.
The Study
Creando Posibilidades was a two-site study
approved by the Institutional Review Boards
(IRBs) of both universities. The purpose was to
examine the trajectory of DE behaviors of col-
lege-enrolled Latinas (Mexican-American/MA)
over a 1-year period, with measurements occur-
ring at 3-month intervals, to ascertain patterns
of risk behaviors over time and to explore
the causal relationship between self-cognitions
(self-schemas) and DE behaviors. The pattern of
associations among DE and alcohol and tobacco
use also were explored. Three speciﬁc aims
were addressed to test the proposed relation-
ships between self-schemas and the risk behav-
iors in MA young adult women: (1) examine the
pattern of associations among DE behaviors and
alcohol and tobacco use; (2) examine the role of
the organizational properties of self-schemas in
predicting the availability of a fat body-weight
self-schema and the severity of DE behaviors;
and (3) examine the association between socio-
cultural factors and the organizational properties
of the self-schema.
Inclusion criteria for the sample were:
(1) (self-identiﬁed) Mexican-American women
between 18 and 35 years, (2) freshman, sopho-
more, or junior (not senior or in ﬁnal year of
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study based on credit status) level student at
community, junior, or 4-year college, and (3)
English speaking. Exclusion criteria included:
current treatment for DE or substance abuse/de-
pendence disorders. Two factors underpinned
the selection of participant characteristics: (1)
literature suggests that rates of DE and tobacco
and heavy alcohol use are higher in MA com-
pared to other groups of Hispanic women
(Bachman, Wallace, & O’Malley, 1991; Nation-
al Institute on Alcohol Abuse and Alcoholism,
2004; National Women’s Information Center,
2003; Swaim & Wayman, 2004; Vega, Sribney,
& Achara-Abrahams, 2003), and (2) the transi-
tion and adjustment to college presents vulner-
abilities to engaging in risk behaviors, such
as DE and tobacco and alcohol use (Brewer,
1994; Nielsen & Ford, 2001; Wechsler, Rigotti,
Gledhill-Hoyt, & Lee, 1998; White, Pandina, &
Chen, 2002).
Individual disclosure obligations emerged
for the eating disorder symptom data. In clinical
practice, eating disorder diagnoses are based on
self-reported behavioral patterns, attitudes to-
wards body weight and shape, and objective
body weight measurement. In this study, a
12-month longitudinal design was used with
measurement of eight DE behaviors (binge-
eating, self-induced vomiting, laxative, diuretic,
or diet pill use, excessive exercise, food restrict-
ing, fasting, alcohol and tobacco use) every
3 months for a total of ﬁve 14-day periods using
EMA methodology. With this measurement ap-
proach, participants recorded their behaviors as
they occurred on a PDA (handheld computer)
and were asked to transfer their data weekly to a
secure website. Participants were weighed at the
beginning of each data collection period, and pa-
per and pencil questionnaires were administered
to measure attitudinal symptoms of the eating
disorders. Symptoms of depression and anxiety
disorders were measured once at baseline.
During the EMA data collection periods,
participants were asked to carry with them at all
times a project-provided PDA and to record all
instances of the target behaviors, with the ex-
ception of food restricting and fasting, which
were measured once a day. A PDA software
program developed for the project began with a
list of the target risk behaviors. Once a partici-
pant endorsed a behavior, a series of follow-up
questions was presented that allowed discrimi-
nation of clinically signiﬁcant levels of the
behaviors. For example, the binge-eating algo-
rithm included questions to verify that the
episode met DSM-IV criteria for binge episode
(i.e., objectively large quantity of food ingested
within a 2-hour period accompanied by subjec-
tive feelings of being out of control). At the end
of each day, participants reported food restrict-
ing and fasting over the last 24-hour period.
The Eating Disorder Inventory (EDI) (Garner,
1991), a measure of the attitudinal symptoms of
eating disorders, was administered at each EMA
data collection point along with a measurement
of objective body weight. The EDI scale
includes 64 items that generate eight subscale
scores, which are computed by summing scores
across all items in the subscale. Criterion-relat-
ed and concurrent validity of the subscales have
been shown with clinical and non-clinical sam-
ples (Garner, 1991). Internal consistency of the
subscales, using Cronbach’s alpha, examined in
samples of Hispanic young females ranged be-
tween .84 and .93 (Joiner & Kashubeck, 1996).
Together, this set of data held the potential
for identiﬁcation of women who were suspected
of meeting diagnostic criteria for anorexia nerv-
osa, bulimia nervosa, and eating disorders not
otherwise speciﬁed. Thus, one issue of dis-
closure within the protocol was whether there
was an obligation to inform participants of the
potential diagnosis and its health consequences.
Support for Individual Disclosure
Arguments favoring individual disclosure of
results are largely founded on the ethical princi-
ples of respect and beneﬁcence. Respect refers
to treatment of individuals as autonomous
agents, capable of making decisions about per-
sonal goals and acting in accordance with those
decisions (The National Commission for the
Protection of Human Subjects of Biomedical
and Behavioral Research, Department of Health,
Education, and Welfare [NCPHS], 1979). The
principle of respect has been used to support the
argument for disclosure in two ways. In the ﬁrst
case, the focus is on the individual as an auton-
omous agent with the capability and right to
seek information. According to this perspective,
participants should be informed that the data
collection procedures will result in the availabil-
ity of individual-speciﬁc information and given
the opportunity to decide whether or not to seek
it (Shalowitz & Miller, 2005). If the individual
seeks information, it should be provided along
with a clear explanation about the certainty and
clinical utility of the information.
The principle of respect also is used as the
foundation for the argument that participants
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should be given individual results when the in-
formation could empower proactive lifestyle
changes in behavior (Dressler, 2009). According
to the Belmont Report, the principle of beneﬁ-
cence is a subset of respect, including two gen-
eral rules viewed as complementary expressions
of the principle of respect: ‘‘do no harm’’ and
‘‘maximize possible beneﬁts and minimize pos-
sible harms’’ (NCPHS, 1979). Some ethicists
have argued that providing participants with in-
dividual results is an obligation grounded in the
principle of beneﬁcence, when information pro-
vides evidence of immediate risk, and interven-
tions to manage or treat the threat are available
(Dressler, 2009; Ravitsky & Wilfond, 2006).
For example, ﬁndings revealing a genetic vul-
nerability to lung cancer hold strong potential
for empowering the individual’s decision-
making related to tobacco use. The failure to
provide individual information collected as part
of the study protocol has the potential to harm
the individual when awareness of the problem
could lead to speciﬁc risk reduction behaviors,
and effective treatment to assist with smoking
cessation is available.
Against Individual Disclosure
Arguments against disclosure span a diverse
range of issues including investigator role clari-
ty, the ethical principle of beneﬁcence in rela-
tion to characteristics of the research ﬁndings,
and resource utilization. Perhaps the broadest
argument against individual disclosure is re-
ferred to in the ethics literature as ‘‘therapeutic
misconception,’’ the potential confusion in the
participant’s understanding of the goals of re-
search and role of the investigator in relation to
these goals. More speciﬁcally, therapeutic mis-
conception occurs when the research participant
does not distinguish between the clinical
research and ordinary treatment and attributes
therapeutic intent to research procedures (Lidz
& Appelbaum, 2002).
The principle of beneﬁcence and its com-
ponent rule to ‘‘do no harm’’ also have been
used to ground the argument against individual
disclosure. This argument focuses on issues
related to the validity of the study ﬁndings, that
is, the quality and quantity of the evidence
(Ravitsky & Wilfond, 2006). For example, if a
study’s aim is to develop a diagnostic test, are
results of the test sufﬁciently reliable to support
disclosure to the participants? If not, how many
replications are necessary before the test can be
considered sufﬁciently reliable to warrant dis-
closure? Similar questions also can be raised
in regard to studies addressing causality. Is it
possible that the ﬁndings can be due to chance,
biases, or confounding? What is the point at
which there is sufﬁcient conﬁdence about the
results? In these uncertain circumstances, harm
is a possible outcome of both positive and nega-
tive results (Dressler, 2009). With positive
results, perhaps indicating the presence of a vul-
nerability to disease, inaccurate results may
cause needless stress and anxiety. In contrast,
a false negative result may lead to false reassur-
ance and inaction when prevention or early
detection is possible.
Several issues further confuse the picture,
one addressing the inﬂuence of individual dis-
closure on study outcomes and risk/beneﬁts as-
sessment. Meltzer (2006) argued that because
the outcome of a study cannot be known before
the study is completed, it is impossible to weigh
whether participants will beneﬁt by gaining po-
tentially useful results. Further, he argued that
even if the information is available, it is un-
knowable whether the participants will perceive
access to this information as a risk or beneﬁt. In
addition to complicating the risk/beneﬁts assess-
ment, under the conditions of individual disclo-
sure, investigators may be more susceptible to
overstating the beneﬁts of enrollment to poten-
tial participants.
Another argument against individual dis-
closure also focuses on the overall goals of
research but extends the discussion to the issue
of utilization of resources. Ethically sound
disclosure of individual ﬁndings requires that
the information not only has validity but
that appropriate supports are available to assist
the participant with issues related to the
disclosure.
One issue that has emerged in this discus-
sion is whether the quality control standards
that guide laboratory testing for clinical use also
should be implemented in the research context.
The Clinical Laboratory Improvement Act of
1988 (Centers for Disease Control, 1988) stipu-
lates that laboratory studies, to be used in the
diagnosis and treatment of humans, must be
completed in a CLIA-compliant laboratory.
Because laboratory studies often are done by
research groups in their own laboratories, ques-
tions have been raised about the obligation
to have the tests redone in a CLIA-compliant
laboratory to ensure analytic validity before
disclosing results to the individual participant
(Shalowitz & Miller, 2005). In this case, the
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burden of cost becomes a key issue in the
debate (Meltzer, 2006).
Similarly, counseling may be appropriate
to assist the individual in making the decision
about receiving research ﬁndings, particularly in
the area of genetics research, but again ques-
tions emerge about the use of research resources
to cover the cost of individual-based services.
Finally, disclosure of ﬁndings raises issues of
patient education and counseling needs at the
time of disclosure, the provision of treatment
referrals, and ultimately, responsibility to cover
the costs of subsequent care. In all cases,
decisions about the appropriate utilization of
resources are multidimensional and complex.
At the center of the issue of disclosure is
the fundamental difference between research
and practice, somewhat narrowly outlined in the
Belmont Report (NCPHS, 1979). Research is
deﬁned as a set of activities designed to achieve
scientiﬁc objectives and contribute generalizable
knowledge. From this viewpoint, the primary
obligation of the researcher is to conduct good
science and contribute knowledge to the general
population (Belsky & Richardson, 2004; Melt-
zer, 2006; Morreim, 2005). In contrast, the fo-
cus of practice is on the health and well-being
of a particular individual. Practice provides di-
agnosis and treatment that are speciﬁcally
designed to meet the needs of individuals. For
the practitioner, the primary obligation is to act
in the best interest of the speciﬁc patient.
The demarcation of the issue of respect for
persons between investigators and clinicians
may become muddy because research involving
human subjects, regardless of its scientiﬁc aims,
must still ensure beneﬁcence and justice. Re-
search using human participants is directed at
providing a good for humans, and not just
knowledge for knowledge’s sake. Further, the
sharp differentiation between research and prac-
tice emphasized in the disclosure literature cre-
ates dissonance for investigators in practice
disciplines. Grace (2009) argued that the obliga-
tion of research extends beyond the focus on
generalizable knowledge for societal good.
According to this view, the individual is the
essential component of society. Therefore, con-
tributions to the general good cannot occur
without attention to the needs and good of the
individual. The rightful emphasis on individual
good as the single pathway to societal good
that underlies the ethics of research in practice
disciplines increases the complexity of the
investigator’s decision-making related to indi-
vidual disclosure.
In summary, conﬂicts stem from the ﬁdu-
ciary (trust) relationship between clinician and
patient, the potential conﬂation of roles between
investigator and clinician, protection of the aims
of the research project in the context of address-
ing the individual’s rights and needs, and the
utilization of resources to both achieve the study
aims and address the needs of the individual
participant. These are examples of the complex
and compelling tensions that must be considered




In implementing Creando Posibilidades, we
attempted to resolve questions regarding the
risks, beneﬁts, and obligations to participants re-
lated to individual disclosure by addressing the
issue collaboratively with co-investigators
across the two study sites, emphasizing mindful
planning and collaboration with the IRBs prior
to the launching of the study protocol. The pro-
cess of deciding whether to identify women at
risk for meeting diagnostic criteria for eating
disorders did not follow a linear path but rather
was modiﬁed over the study design period by
conferencing and seeking recommendations
from the IRBs.
The EMA data presented a special case for
disclosure in that they provided an unusually
speciﬁc account of patterns of risk behaviors.
Unlike many measures of eating disorder symp-
tomatology that have limited diagnostic utility,
the EMA records provided detailed information
about speciﬁc behaviors and the patterns of
behaviors over time. For example, laxative use
is considered a purging behavior only when it is
taken for the purposes of ‘‘getting rid of’’
ingested food as a means to lose weight or pre-
vent weight gain. Similarly, an episode of eating
is considered an objective binge episode only
when: (1) the quantity of food ingested was
larger than most others would eat in similar
circumstances, (2) it occurred within a 2-hour
interval, and (3) it was accompanied by feelings
of being out of control. These speciﬁc attributes
were queried in Creando each time a target be-
havior was recorded. Further, the EMA data
captured the weekly frequencies of behaviors,
information which can be used to establish an
eating disorder diagnosis.
There were several additional reasons why
disclosure was an important issue for this study.
INDIVIDUAL DISCLOSURE/STEIN ET AL. 315
Research in Nursing & Health
First, despite the fact that women know they are
engaging in these behaviors, women often do
not know the physical health consequences of
DE behaviors (Le Grange, Swanson, Crow, &
Merikangas, 2012). Further, recent studies have
shown convincingly that sub-threshold levels of
DE behaviors, patterns of behaviors at lower se-
verity than required for the diagnosis, have sig-
niﬁcant, if not equal, physical and mental health
consequences (Patton, Coffey, Carlin, Sanci, &
Sawyer, 2008). Finally, the eating disorders, in-
cluding anorexia nervosa, bulimia nervosa, and
eating disorders not otherwise speciﬁed, are
most easily and successfully treated at the early
stages of the illness before the behaviors have
consolidated into a stable syndrome (Treasure
& Russell, 2011). From this perspective, disclo-
sure of individual information for women with
signs of an eating disorder may empower them
to seek treatment and make health-directed
behavior change.
Identification of Potentially Meaningful
Information
Once study measures and procedures were iden-
tiﬁed during the research planning stage, the
ﬁrst issue addressed was the potential clinical
utility of the data at the individual level. Cur-
rently no speciﬁc guidelines exist for determin-
ing ‘‘direct clinical utility’’ within clinical and
behavioral research [see Miller et al. (2008) for
a referenced discussion]. However, Sharp and
Orr (2004) suggested that clinical utility could
proﬁtably be deﬁned as information related to a
life-threatening condition or signs and symp-
toms of potentially treatable disorders. This def-
inition enables distinction between measures
designed to detect clinical conditions (e.g.,
Structured Clinical Interview for DSM-IV, Beck
Depression Inventory [BDI], blood pressure)
and other measures designed to tap constructs
with less direct clinical signiﬁcance (e.g., Posi-
tive and Negative Affect State Measure—
PANAS; Measure of Hostility).
In addition to determining whether meas-
ures hold potential for generating clinically im-
portant information for individual participants,
decisions regarding the threshold point for dis-
closure must be made prior to the start of a
study (Sharp & Orr, 2004). Clinical standards
and empirical evidence supporting sensitivity
and speciﬁcity of a measure for a deﬁned popu-
lation can be used as guidelines when establish-
ing a reporting threshold. For example, study
results suggest that a score of 4 or higher on the
Beck Depression Inventory for Primary Care
has 97% sensitivity and 99% speciﬁcity for
identifying adult outpatients with and without
a current major depressive disorder (Steer,
Cavalieri, Leonard, & Beck, 1999).
For Creando Posibilidades, issues of sensi-
tivity and speciﬁcity were not applicable to the
EMA data, and threshold points not easily deter-
mined for the EDI. Although alcohol intake was
assessed, the issue of individual disclosure was
not addressed relative to at-risk levels of alcohol
use behaviors. One reason that this issue was
not raised by the research team or the IRBs was
that amount of alcohol intake does not provide
diagnostic information about DSM-IV alcohol
abuse or dependence diagnoses. However, re-
cent evidence of the sensitivity and speciﬁcity
of a single alcohol screening question and the
effectiveness of brief interventions (McCance-
Katz & Satterﬁeld, 2012) point to the need for
future researchers who collect alcohol intake
data to address the issue of disclosure.
Plans for Monitoring Data
Research data collection activities often are han-
dled by auxiliary research staff, and very fre-
quently the principal investigator is not involved
in monitoring the data as they are collected.
Therefore, speciﬁc plans for Creando Possbili-
dades were developed to identify who would be
responsible for monitoring the clinically rele-
vant measures to identify individuals who
scored above the threshold for disclosure. Fur-
thermore, speciﬁc plans for the timeline and
management of the information were deter-
mined. For paper-and-pencil questionnaires like
the BDI, responsibility for computing the score
and the timeline for doing so were clearly speci-
ﬁed. Each data collector would be required
to compute the scale score immediately after
conclusion of the data collection session. Scores
over the reported threshold would trigger com-
munication with the principal investigator so
that plans for disclosure to the participant could
be arranged.
Plans for Disclosing Information to
Individual Participants
An important point of team consensus was that
if implemented, individual disclosure should
be addressed in the informed consent process
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(Dressler, 2009; Shalowitz & Miller, 2005). A
detailed description of the information and the
circumstance that would trigger disclosure was
articulated in the informed consent form. Addi-
tional planning identiﬁed the research staff per-
son who would be responsible for disclosing
information to the study participant. Details
such as the qualiﬁcations and/or training re-
quired for persons assuming this responsibility
and the format of the disclosure meeting were
speciﬁed. Although it was decided that the prin-
cipal investigator would assume primary respon-
sibility, issues such as the importance of an
established relationship were discussed to deter-
mine whether other research staff, such as the
data collector, might be more appropriate to
assume the responsibility.
Timing of Disclosure
The timing of the disclosure required consider-
ation of both the nature of the health information
and the implications for the study protocol. Infor-
mation that has immediate and life-threatening
consequences for the individual, such as suicide
intent, was judged clearly to take precedence
over all other concerns. However, discussion
about the timing of disclosure of other non-life
threatening information considered the implica-
tions for the study protocol and the investigator’s
obligation to conduct scientiﬁcally sound re-
search that contributes generalizable knowledge.
In this study, EMA data were collected at
ﬁve points during the 12-month protocol, includ-
ing baseline, 3, 6, 9, and 12 months. Although
early treatment-seeking would improve the par-
ticipant’s likelihood of recovery, disclosure dur-
ing the protocol held strong potential for biasing
the data, thereby compromising the ethical obli-
gation to utilize funding resources to achieve the
stated scientiﬁc objectives. For example, discus-
sing alarming behavior patterns with the partici-
pant during the study protocol would create
the possibilities that the participant would not
be comfortable continuing to report behaviors
during subsequent measurement periods, or that
the feedback would lead to a project-induced
decision to seek treatment, which would likely
alter the natural course of behaviors.
Use of Study Resources
Another important factor inﬂuencing the deci-
sion regarding individual disclosure was the
feasibility and costs associated with monitoring
participant data for signs of an eating disorder.
The target sample for this study was 540 wom-
en, with data collection coordinated at two re-
search sites. At each EMA data collection point,
participants were asked to download their data
from the PDA to a secure website at least once
weekly during each 14-day recording episode.
Identiﬁcation of cases with a potential eating
disorder would require an ongoing detailed re-
view and evaluation of these EMA data and
their synthesis with other measures of eating
disorder attitudes, including the EDI. In the end,
the use of resources to engage in clinical diag-
nostic activities was deemed incongruent with
the explicit study purpose to investigate the role
of properties of knowledge structures related to
the self (e.g., self-schemas) in predicting risk
behavior trajectories over a 12-month period.
While we could not separate the obligations of
‘‘do no harm’’ and ‘‘promote the good’’ from
their congruent obligations in both practice and
research, we did evaluate whether the focus of
the research (study purpose) might be diluted or
not achieved if the care obligations subsequent
to follow-up diagnostic procedures became a
study activity.
Contract With Participants
A ﬁnal issue we considered was the context of
the research study and the participants’ expect-
ations about participation and desire for individ-
ual speciﬁc feedback. For this study, women
were recruited from their college settings based
on ethnic background, age, and enrollment in
school, and all data collection activities were
completed at the participant’s campus. The in-
formed consent clearly stated that the purpose
of the study was to learn about factors that con-
tribute to health risk behaviors, and the speciﬁc
behaviors measured were clearly speciﬁed and
deﬁned. However, study participants were not
recruited for health problems, nor were they
recruited from a health care site. Therefore, par-
ticipants did not enter into a relationship with
the research team in the context of seeking
health care services or in response to a per-
ceived health care need. Rather, participants
contacted the research team in response to
advertisements seeking participants for a re-
search study that would include monetary remu-
neration for participation. Prior to enrollment,
the investigators did not discuss with the partic-
ipants their personal preferences for receiving
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individualized health-related information that
was collected as part of participation in this
study. Within this context, it was unlikely that
the participant was seeking or expecting person-
alized information about her health status as an
outcome of participation.
Thus, although the initial plans and consent
process included a plan for disclosing to partic-
ipants if they were at risk, after team discussion
regarding the nature of study data, the relative
risk of disclosure related to participant health
and continuation in the study, and recommenda-
tions from our IRB, the team chose not to dis-
close data assessments of at-risk behaviors for
eating disorders. Instead, the IRBs recom-
mended that the last data collection session of
the study include the provision of information
about eating disorder symptoms and treatment
options. At the ﬁnal debrieﬁng session, each
participant was given a description of the signs
and symptoms of the eating disorders and a list
of potential treatment options, both verbally and
in writing. The protocol required that the re-
search assistant verbally provide information
about the symptoms of anorexia nervosa, bulim-
ia nervosa, and binge eating disorder, along
with a brief summary of the potential health
consequences of these behaviors. This informa-
tion also was given to each participant in a writ-
ten pamphlet along with a list of treatment
centers in the area.
Summary and Conclusions
The Creando Posibilidades study provides an
example of the array of complexities that can
emerge within a clinical study when considering
disclosure of individual results, and how these
considerations may be mutable during project
implementation. Although the fundamental value
of caring that underlies health-related disciplines
may lead clinical investigators to automatically
conclude that disclosure is an obvious and non-
debatable obligation, the arguments supporting
and challenging disclosure point to the complex-
ities involved. Clinical investigators, like all
scientists, have critical obligations to generate
knowledge that will contribute to the general
good as well as address the needs and good of
the individual. Furthermore, investigators cannot
assume that disclosure is the desired choice for
study participants or that disclosure itself has
no risks. Mindful consideration of the nature of
information that will be collected, on-going
discourse about the pros and cons of disclosure
within the research team, and initial discussion
and continuing review with the appropriate regu-
latory body are essential aspects of study plan-
ning for all health-related research that involves
human subjects.
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